245 related articles for article (PubMed ID: 30030413)
1. Comparison of lente insulin and NPH insulin therapy for the treatment of newly diagnosed diabetic dogs: a randomised study.
Fracassi F; Linari G; Del Baldo F; Di Cunzolo A; D'Angelo S; Malerba E; Carotenuto G; Bonfanti U; Corradini S
Vet Rec; 2018 Sep; 183(8):262. PubMed ID: 30030413
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of protamine zinc recombinant human insulin for controlling hyperglycemia in dogs with diabetes mellitus.
Maggiore AD; Nelson RW; Dennis J; Johnson E; Kass PH
J Vet Intern Med; 2012; 26(1):109-15. PubMed ID: 22211582
[TBL] [Abstract][Full Text] [Related]
3. Long-term field study of lispro and neutral protamine Hagedorn insulins treatment in dogs with diabetes mellitus.
Kuzi S; Mazaki-Tovi M; Hershkovitz S; Yas E; Hess RS
Vet Med Sci; 2023 Mar; 9(2):704-711. PubMed ID: 36795089
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of a protocol for transitioning porcine lente insulin-treated diabetic cats to human recombinant protamine zinc insulin.
Gostelow R; Hazuchova K; Scudder C; Forcada Y; Church D; Niessen SJ
J Feline Med Surg; 2018 Feb; 20(2):114-121. PubMed ID: 29172917
[TBL] [Abstract][Full Text] [Related]
5. Effects of treatment with lispro and neutral protamine Hagedorn insulins on serum fructosamine and postprandial blood glucose concentrations in dogs with clinically well-controlled diabetes mellitus and postprandial hyperglycemia.
Bertalan AV; Drobatz KJ; Hess RS
Am J Vet Res; 2020 Feb; 81(2):153-158. PubMed ID: 31985281
[TBL] [Abstract][Full Text] [Related]
6. Use of insulin glargine in dogs with diabetes mellitus.
Fracassi F; Boretti FS; Sieber-Ruckstuhl NS; Reusch CE
Vet Rec; 2012 Jan; 170(2):52. PubMed ID: 22008227
[TBL] [Abstract][Full Text] [Related]
7. Intermediate-acting insulin preparations: NPH and lente.
Deckert T
Diabetes Care; 1980; 3(5):623-6. PubMed ID: 7192205
[TBL] [Abstract][Full Text] [Related]
8. An investigation of the action of Neutral Protamine Hagedorn human analogue insulin in dogs with naturally occurring diabetes mellitus.
Palm CA; Boston RC; Refsal KR; Hess RS
J Vet Intern Med; 2009; 23(1):50-5. PubMed ID: 19175720
[TBL] [Abstract][Full Text] [Related]
9. Double-blind crossover trial of isophane (NPH)- and lente-based insulin regimens.
Tunbridge FK; Newens A; Home PD; Davis SN; Murphy M; Burrin JM; Alberti KG; Jensen I
Diabetes Care; 1989 Feb; 12(2):115-9. PubMed ID: 2649324
[TBL] [Abstract][Full Text] [Related]
10. Comparing lente insulin and NPH insulin for treating diabetic dogs.
Lathan P; Fleeman L
Vet Rec; 2018 Sep; 183(8):260-261. PubMed ID: 30171114
[No Abstract] [Full Text] [Related]
11. Management of cats on Lente insulin: tips and traps.
Caney SM
Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):267-82. PubMed ID: 23522172
[TBL] [Abstract][Full Text] [Related]
12. Time-action profiles of insulin degludec in healthy dogs and its effects on glycemic control in diabetic dogs.
Oda H; Mori A; Ishii S; Shono S; Onozawa E; Sako T
J Vet Med Sci; 2018 Nov; 80(11):1720-1723. PubMed ID: 30305465
[TBL] [Abstract][Full Text] [Related]
13. Detemir insulin for the treatment of diabetes mellitus in dogs.
Fracassi F; Corradini S; Hafner M; Boretti FS; Sieber-Ruckstuhl NS; Reusch CE
J Am Vet Med Assoc; 2015 Jul; 247(1):73-8. PubMed ID: 26086231
[TBL] [Abstract][Full Text] [Related]
14. Management of canine diabetes.
Fleeman LM; Rand JS
Vet Clin North Am Small Anim Pract; 2001 Sep; 31(5):855-80, vi. PubMed ID: 11570130
[TBL] [Abstract][Full Text] [Related]
15. Use of glargine and lente insulins in cats with diabetes mellitus.
Weaver KE; Rozanski EA; Mahony OM; Chan DL; Freeman LM
J Vet Intern Med; 2006; 20(2):234-8. PubMed ID: 16594577
[TBL] [Abstract][Full Text] [Related]
16. Replacing Insulin Glargine with Neutral Protamine Hagedorn (NPH) Insulin in a Subpopulation of Study Subjects in the Action to Control Cardiovascular Risk in Diabetes (ACCORD): Effects on Blood Glucose Levels, Hypoglycemia and Patient Satisfaction.
Berard L; Cameron B; Woo V; Stewart J
Can J Diabetes; 2015 Aug; 39(4):296-301. PubMed ID: 25819531
[TBL] [Abstract][Full Text] [Related]
17. Insulin Therapy in Small Animals, Part 1: General Principles.
Fleeman L; Gilor C
Vet Clin North Am Small Anim Pract; 2023 May; 53(3):615-633. PubMed ID: 36906469
[TBL] [Abstract][Full Text] [Related]
18. Effect of the sodium-glucose cotransporter-2 inhibitor, DWP16001, as an add-on therapy to insulin for diabetic dogs: A pilot study.
An JH; Choi HS; Choi JS; Lim HW; Huh W; Oh YI; Park JS; Han J; Lim S; Lim CY; Kim TH; Moon JB; Youn HY
Vet Med Sci; 2024 May; 10(3):e1454. PubMed ID: 38686463
[TBL] [Abstract][Full Text] [Related]
19. Anti-insulin antibodies in diabetic dogs before and after treatment with different insulin preparations.
Davison LJ; Walding B; Herrtage ME; Catchpole B
J Vet Intern Med; 2008; 22(6):1317-25. PubMed ID: 18976287
[TBL] [Abstract][Full Text] [Related]
20. Treatment of diabetes mellitus in dogs using isophane insulin penfills and the use of serum fructosamine assays to diagnose and monitor the disease.
Thoresen SI; Lorenzen FH
Acta Vet Scand; 1997; 38(2):137-46. PubMed ID: 9257449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
